Skip to content

Agilon Health AGL Impairment Charges

Impairment Charges at other companies

Clover Health Investments logo
Clover Health InvestmentsCLOV
$0

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Agilon Health’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's impairment charges?
Agilon Health (AGL) reported impairment charges of $9.02M in Q4 2025.
How has Agilon Health's impairment charges changed year-over-year?
Agilon Health's impairment charges increased by 903.5% year-over-year, from $899K to $9.02M.
What does impairment charges mean?
Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.